# Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

> **NCT00849615** · PHASE2 · COMPLETED · sponsor: **Krankenhaus Nordwest** · enrollment: 252 (actual)

## Conditions studied

- Gastric Cancer
- Adenocarcinoma of the Esophagogastric Junction

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** 5-Fluorouracil
- **DRUG:** Oxaliplatin
- **DRUG:** folinic acid

## Key facts

- **NCT ID:** NCT00849615
- **Lead sponsor:** Krankenhaus Nordwest
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2012-01
- **Final completion:** 2016-01
- **Target enrollment:** 252 (ACTUAL)
- **Last updated:** 2016-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00849615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00849615, "Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00849615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*